Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

China flag China · Delayed Price · Currency is CNY
34.97
+2.18 (6.65%)
At close: Jul 10, 2025, 2:57 PM CST
16.57%
Market Cap 5.25B
Revenue (ttm) 478.74M
Net Income (ttm) 212.91M
Shares Out 160.56M
EPS (ttm) 1.47
PE Ratio 22.25
Forward PE n/a
Dividend 1.50 (4.44%)
Ex-Dividend Date Jun 10, 2025
Volume 12,204,375
Average Volume 4,890,028
Open 32.64
Previous Close 32.79
Day's Range 32.35 - 35.25
52-Week Range 20.50 - 39.50
Beta n/a
RSI 58.74
Earnings Date Aug 26, 2025

About SHA:603207

Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics, otorhinolaryngology, and disinfection. Shanghai Xiao Fang Pharmaceutical Co., Ltd was founded in 1993 and is based in Shanghai, China. [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603207
Full Company Profile

Financial Performance

In 2024, SHA:603207's revenue was 474.58 million, an increase of 0.57% compared to the previous year's 471.87 million. Earnings were 205.27 million, an increase of 0.81%.

Financial Statements

News

There is no news available yet.